Our customers' Feedback
Search:
Perform search
Categories list

Generic Januvia

News
Januvia
Januvia photo

Generic Januvia (Sitagliptin Phosphate)

Diabetes

PackagePricePer PillSavingsOrder
25mg × 14 pills$59.95$4.28Add to cart
25mg × 28 pills$114.95$4.11$4.95Add to cart
25mg × 56 pills$204.95$3.66$34.85Add to cart
25mg × 84 pills$299.95$3.57$59.75Add to cart

PackagePricePer PillSavingsOrder
50mg × 14 pills$64.95$4.64Add to cart
50mg × 28 pills$119.95$4.28$9.95Add to cart
50mg × 56 pills$214.95$3.84$44.85Add to cart
50mg × 84 pills$319.95$3.81$69.75Add to cart

PackagePricePer PillSavingsOrder
100mg × 14 pills$69.95$5.00Add to cart
100mg × 28 pills$124.95$4.46$14.95Add to cart
100mg × 56 pills$219.95$3.93$59.85Add to cart
100mg × 84 pills$324.95$3.87$94.75Add to cart

Most popular quantity.
Metaglip
$ 0.50
Generic Metaglip
(Glipizide - Metformin 2.5mg + 250mg)
Micronase
$ 0.44
Generic Micronase
(Glyburide(glibenclamide) 1.25/2.5/5mg)
Onglyza
$ 3.21
Generic Onglyza
(Saxagliptin 5mg)
Prandin
$ 0.83
Generic Prandin
(Repaglinide 0.5/1/2mg)
Precose
$ 0.96
Generic Precose
(Acarbose 25/50mg)
Starlix
$ 0.83
Generic Starlix
(Nateglinide 60/120mg)
Social bookmarks:
Choose your language:



Money backguarantee
Secureshopping

Our billing is certified by:

Secure shopping certificates

Special Offer!

  • Sanofi nabs long-sought FDA approval for daily GLP-1 contender Adlyxin - FiercePharma

    FiercePharmaSanofi nabs long-sought FDA approval for daily GLP-1 contender AdlyxinFiercePharmaAfter topping its potential rival Bydureon and the DPP-4 blockbuster Januvia in separate trials, semaglutide is set to go to the FDA for approval later this year, with a potential launch in late 2017.

  • Merck's 2Q16 Estimates: Expected Growth Contributors - Market Realist

    Market RealistMerck's 2Q16 Estimates: Expected Growth ContributorsMarket RealistAs discussed earlier, nearly 90% of total 2Q16 revenue for Merck and Co.

  • Why Investors Can Expect Operational Growth from Merck in 2Q16 - Market Realist

    Why Investors Can Expect Operational Growth from Merck in 2Q16Market RealistThese drugs include Januvia, Janumet, Zetia, Vytorin, Remicade, Isentress, Gardasil, Proquad/Varivax, and Cubicin.

  • Novo's weekly GLP-1 aces two head-to-head trials against Januvia, Bydureon - FiercePharma

    FiercePharmaNovo's weekly GLP-1 aces two head-to-head trials against Januvia, BydureonFiercePharmaThe Novo drug beat Januvia by a bigger margin, with reductions in A1C of 1.

  • Can Keytruda Deliver Earnings Growth For Merck? - Benzinga

    BenzingaCan Keytruda Deliver Earnings Growth For Merck?BenzingaMRK might also see a sales boost from Zepatier, which fights hepatitis C, and Januvia, a Type 2 diabetes medication.

    Copyright © cheapgenerics24.com